Implementation of the WHO standards to assess the quality of care for children with acute diarrhoea: findings of a multicentre study (CHOICE) in Italy.


Journal

BMJ paediatrics open
ISSN: 2399-9772
Titre abrégé: BMJ Paediatr Open
Pays: England
ID NLM: 101715309

Informations de publication

Date de publication:
30 Aug 2024
Historique:
received: 06 02 2024
accepted: 12 05 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 30 8 2024
Statut: epublish

Résumé

There is no documented experience in the use of the WHO standards for improving the quality of care (QOC) for children at the facility level. We describe the use of 10 prioritised WHO-Standard-based Quality Measures to assess QOC for children with acute diarrhoea (AD) in Italy. In a multicentre observational study in 11 paediatric emergency departments with different characteristics and geographical location, we collected data on 3061 children aged 6 months to 15 years with AD and no complications. Univariate and multivariate analyses were conducted. Study findings highlighted both good practices and gaps in QoC, with major differences in QOC across facilities. Documentation of body weight and temperature varied from 7.7% to 98.5% and from 50% to 97.7%, respectively (p<0.001); antibiotic and probiotic prescription rates ranged from 0% to 10.1% and from 0% to 80.8%, respectively (p<0.001); hospitalisations rates ranged between 8.5% and 62.8% (p<0.001); written indications for reassessment were provided in 10.4%-90.2% of cases (p<0.001). When corrected for children's individual characteristics, the variable more consistently associated with each analysed outcome was the individual facility. Higher rates of antibiotics prescription (+7.6%, p=0.04) and hospitalisation (+52.9%, p<0.001) were observed for facilities in Southern Italy, compared with university centres (-36%, p<0.001), independently from children characteristics. Children's clinical characteristics in each centre were not associated with either hospitalisation or antibiotic prescription rates. The 10 prioritised WHO-Standard-based Quality Measures allow a rapid assessment of QOC in children with AD. Action is needed to identify and implement sustainable and effective interventions to ensure high QOC for all children.

Sections du résumé

BACKGROUND BACKGROUND
There is no documented experience in the use of the WHO standards for improving the quality of care (QOC) for children at the facility level. We describe the use of 10 prioritised WHO-Standard-based Quality Measures to assess QOC for children with acute diarrhoea (AD) in Italy.
METHODS METHODS
In a multicentre observational study in 11 paediatric emergency departments with different characteristics and geographical location, we collected data on 3061 children aged 6 months to 15 years with AD and no complications. Univariate and multivariate analyses were conducted.
RESULTS RESULTS
Study findings highlighted both good practices and gaps in QoC, with major differences in QOC across facilities. Documentation of body weight and temperature varied from 7.7% to 98.5% and from 50% to 97.7%, respectively (p<0.001); antibiotic and probiotic prescription rates ranged from 0% to 10.1% and from 0% to 80.8%, respectively (p<0.001); hospitalisations rates ranged between 8.5% and 62.8% (p<0.001); written indications for reassessment were provided in 10.4%-90.2% of cases (p<0.001). When corrected for children's individual characteristics, the variable more consistently associated with each analysed outcome was the individual facility. Higher rates of antibiotics prescription (+7.6%, p=0.04) and hospitalisation (+52.9%, p<0.001) were observed for facilities in Southern Italy, compared with university centres (-36%, p<0.001), independently from children characteristics. Children's clinical characteristics in each centre were not associated with either hospitalisation or antibiotic prescription rates.
CONCLUSIONS CONCLUSIONS
The 10 prioritised WHO-Standard-based Quality Measures allow a rapid assessment of QOC in children with AD. Action is needed to identify and implement sustainable and effective interventions to ensure high QOC for all children.

Identifiants

pubmed: 39214557
pii: 10.1136/bmjpo-2024-002569
doi: 10.1136/bmjpo-2024-002569
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Investigateurs

Kevin Valentino (K)
Chiara Grisaffi (C)
Fabio Cardinale (F)
Annunziata Lucarelli (A)
Lucia Grazia Tricarico (LG)
Mariateresa De Sario (M)
Alessandra Pisani (A)
Maria Carla Finocchiaro (MC)
Laura Portale (L)
Francesca Patanè (F)
Vita Antonella Di Stefano (VA)
Stefano Masi (S)
Marco Greco (M)
Emiliano Talanti (E)
Andrea Iuorio (A)
Anna Madera (A)
Paola Stillo (P)
Rosa Santangelo (R)
Nicolò Chiti (N)
Vanessa Martucci (V)
Silvia Bloise (S)
Alessia Marcellino (A)
Silvia Sordelli (S)
Maria Luisa Casciana (ML)
Francesca Tirelli (F)
Massimo Lo Verde (ML)
Domenico Cipolla (D)
Sarah Contorno (S)
Roberta Parrino (R)
Giuseppina De Rosa (G)
Federico Marchetti (F)
Alessandra Iacono (A)
Vanna Graziani (V)
Carlotta Farneti (C)
Francesco Oppido (F)
Giulia Sansovini (G)
Chiara Stefani (C)
Marcella Massarotto (M)
Paola Crotti (P)
Giada Sartor (G)
Benedetta Ferro (B)
Riccardo Pavanello (R)
Marta Minute (M)
Egidio Barbi (E)
Ilaria Mariani (I)
Elia Balestra (E)
Benmario Castaldo (B)
Marta Magnolato (M)
Michele Maiola (M)
Giorgio Cozzi (G)
Alessandro Amaddeo (A)
Alice Del Colle (AD)
Massimo Dagnelut (M)
Maristella Toniutti (M)
Sara Rivellini (S)
Chiara Pilotto (C)
Paola Cogo (P)

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Marzia Lazzerini (M)

Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.
London School of Hygiene & Tropical Medicine, London, UK.

Idanna Sforzi (I)

Department of Pediatric Emergency Medicine and Trauma Center, IRCCS Meyer Children's University Hospital, Florence, Italy.

Ilaria Liguoro (I)

Santa Maria della Misericordia University Hospital, Udine, Friuli-Venezia Giulia, Italy.

Enrico Felici (E)

Azienda Ospedaliera Nazionale Santi Antonio e Biagio e Cesare Arrigo Alessandria, Alessandria, Piemonte, Italy.

Stefano Martelossi (S)

Department of Pediatrics, Treviso Hospital, Treviso, Italy.

Silvia Bressan (S)

Department of Women's and Children's Health, University of Padova, Padova, Italy.

Gian Luca Trobia (GL)

Azienda Ospedaliera Cannizzaro, Catania, Italy.

Riccardo Lubrano (R)

Department of Pediatrics Sapienza University of Rome, Santa Maria Goretti Hospital, Latina, Italy.

Silvia Fasoli (S)

Department of Pediatrics, "Carlo Poma" Hospital, Mantova, Italy.

Angela Troisi (A)

Department of Pediatrics, Santa Maria delle Croci Hospital, Ravenna, Italy.

Michela Pandullo (M)

Santa Maria della Misericordia University Hospital, Udine, Friuli-Venezia Giulia, Italy.

Marta Gagliardi (M)

Azienda Ospedaliera Nazionale Santi Antonio e Biagio e Cesare Arrigo Alessandria, Alessandria, Piemonte, Italy.

Paola Moras (P)

Department of Pediatrics, Treviso Hospital, Treviso, Italy.

Silvia Galiazzo (S)

Department of Women's and Children's Health, University of Padova, Padova, Italy.

Marta Arrabito (M)

Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.

Mariateresa Sanseviero (M)

Department of Pediatrics Sapienza University of Rome, Santa Maria Goretti Hospital, Latina, Italy.

Mariangela Labruzzo (M)

Department of Pediatrics, "Carlo Poma" Hospital, Mantova, Italy.

Sara Dal Bo (S)

Department of Pediatrics, Santa Maria delle Croci Hospital, Ravenna, Italy.

Valentina Baltag (V)

Department of Maternal, Newborn, Child and Adolescent Health and Ageing, World Health Organization, Geneva, Switzerland.

Paolo Dalena (P)

Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy paolo.dalena@burlo.trieste.it.
University of Trieste, Trieste, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH